REQUEST A DEMO
Total
USD $0.00
Search more companies

Hansoh Pharmaceutical Group Company Limited (Hong Kong) (翰森制药集团有限公司 (香港)) (Hong Kong SAR, China)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Hansoh Pharmaceutical Group Company Limited Profile Updated: January 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Hansoh Pharmaceutical Group Company Limited (Hong Kong) (翰森制药集团有限公司 (香港)) is based in Hong Kong SAR, China, with the head office in Lianyungang. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on April 04, 2026. 8,989 (2024) employees currently work for Hansoh Pharmaceutical Group Company Limited (Hong Kong) (翰森制药集团有限公司 (香港)). There was a net sales revenue increase of 12.63% reported in Hansoh Pharmaceutical Group Company Limited (Hong Kong) (翰森制药集团有限公司 (香港))’s latest financial highlights for Q2C2025. Its total assets grew by 10.83% over the same period. The net profit margin of Hansoh Pharmaceutical Group Company Limited (Hong Kong) (翰森制药集团有限公司 (香港)) increased by 0.27% in 2025.

Headquarters
9 Dongjin Road, Economic Technical Development Zone, Lianyungang
Lianyungang; Jiangsu; Postal Code: 222069

Contact Details: Purchase the Hansoh Pharmaceutical Group Company Limited (Hong Kong) (翰森制药集团有限公司 (香港)) report to view the information.

Website: http://www.hspharm.com

Basic Information
Total Employees:
Purchase the Hansoh Pharmaceutical Group Company Limited (Hong Kong) (翰森制药集团有限公司 (香港)) report to view the information.
Outstanding Shares:
Purchase the Hansoh Pharmaceutical Group Company Limited (Hong Kong) (翰森制药集团有限公司 (香港)) report to view the information.
Registered Capital:
Purchase the Hansoh Pharmaceutical Group Company Limited (Hong Kong) (翰森制药集团有限公司 (香港)) report to view the information.
Financial Auditors:
Purchase the Hansoh Pharmaceutical Group Company Limited (Hong Kong) (翰森制药集团有限公司 (香港)) report to view the information.
Incorporation Date:
April 04, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
65.7%
Purchase this report to view the information.
15.5%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Changzhou Hengbang Pharmaceutical Co., Ltd. ('Changzhou Hengbang') (China)
100%
Hansoh (Shanghai) Health Technology Co., Ltd. (China)
100%
Hansoh Investment Co., Ltd. ('Hansoh Investment') (China)
100%
Company Performance
Financial values in the chart are available after Hansoh Pharmaceutical Group Company Limited (Hong Kong) (翰森制药集团有限公司 (香港)) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
12.63%
Total Operating Revenue
12.99%
Operating Profit
22%
EBITDA
16.38%
Net Profit/Loss for the Period
13.38%
Total Assets
10.83%
Total Equity
11.54%
Operating Profit Margin
3.32%
Net Profit Margin
0.27%
Return on Equity (ROE)
0.31%
Debt / Equity
-72%
Quick Ratio
492.73%
Cash Ratio
-0.73%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?